Join Gregory Curfman, JAMA Executive Editor, and Robert O. Bonow, JAMA Cardiology Editor, as they delve into groundbreaking research from the European Society of Cardiology Congress. They discuss the rise of remote monitoring for detecting asymptomatic atrial fibrillation, the benefits of semaglutide and tirzepatide for heart failure, and findings that show improved outcomes from complete revascularization in myocardial infarction. They also highlight important vaccination insights and the ongoing challenges of women’s participation in cardiovascular research.
